Quarter
Charts

ARMATA PHARMACEUTICALS, INC.

ARMP

CIK 0000921114 · Quarterly mode · latest period FY2020 (Q2) (ending 2020-06-30) · sourced from SEC EDGAR

At a glance · FY2020 (Q2)

Revenue
$31K
Gross Profit
$31K

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
20/100
  • Profitability
    84ROIC 21.7% (10% = solid, 20%+ = moat)
  • Liquidity
    35Current Ratio 1.19 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Insufficient data
  • Growth
    0Insufficient data
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$542K
investment in PP&E
Dividends paid (TTM)
—
cash returned to holders
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$77M
everything owned
Total liabilities
$295M
everything owed
Stockholders' equity
$-219M
shareholder claim

Recent performance · 52 quarters

Revenue
$31K
Net Income↓-386.7% -$21M
$-27M
Free Cash Flow
$-52K
Operating Margin
-14806.5%

Drill down

ARMP Sankey

See ARMATA PHARMACEUTICALS, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

ARMP Charts

52 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

ARMP Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics